Your browser doesn't support javascript.
loading
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study.
Aggarwal, Nidhi; Manley, Ash Lee; Shalhoub, Ruba; Durrani, Jibran; Rios, Olga; Lotter, Jennifer; Patel, Bhavisha A; Wu, Colin O; Young, Neal S; Groarke, Emma M.
Afiliación
  • Aggarwal N; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Manley AL; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Shalhoub R; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Durrani J; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Rios O; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Lotter J; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Patel BA; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Wu CO; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Young NS; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Groarke EM; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
Am J Hematol ; 98(6): 932-939, 2023 06.
Article en En | MEDLINE | ID: mdl-37021397

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunosupresores / Anemia Aplásica Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunosupresores / Anemia Aplásica Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article